713-660-1100

Case Report – “XYZ”

XYZ is a 60 year old white male (DOB 9/1953) with residual aphasia from a mild stroke suffered on 7/6/2010. His business consulting work requires extensive communication skills and the language difficulties have been quite noticeable to him. He is quite high functioning and has managed without his clients noticing the aphasia through a combination of speech therapy, mental focus, and having his wife proofread all of his written communications before he sends them out. The speech therapist says that his language usage is technically correct (and hence generally unnoticeable) with an ESL pattern of someone who is now (re) learning English as a Second Language.

His neurologist recently noted that his recovery has stabilized and reached a plateau without much further improvement. He and his wife felt that improvement was still occurring, although quite slowly.In this situation of a relatively stable neurologic defect, it seemed reasonable to find out if his situation could change with a trial of Nexalin treatments. He and his wife were a bit skeptical and concerned about jeopardizing his current progress. He decided to try just one session on 11/6/2013. His wife thought that his language fluency improved in his writing and his emails (better language output). He returned for a second session on 11/14/2013 and noticed that his language comprehension improved (better language input). With these encouraging results, he continued daily Nexalin sessions on weekdays for a total of 10 treatments finishing on 11/26/2013.

At the end of the series, he reported that many of his vocabulary words have returned from a previous limbo status and that his wife is now frequently noticing error free emails. No quantitative measurements were done, but he and his wife are quite convinced that his progress is definitely faster than he had been experiencing before the Nexalin treatments. We decided to allow a month to pass without treatment to monitor for delayed improvement.

Nexalin may be an effective treatment for the neurologic defects of stroke and possibly
other forms of brain injury. It would be interesting to see more case reports and for
someone to conduct a small study.

— James Hu, MD 11/30/2013

Desktop Tablet Mobile